大动脉动脉瘤:当前的病原和治疗点
Min Ji Cho1, Mi-Ran Lee2, Jong-Gil Park3,4
1Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Experimental & molecular medicine
|November 30, 2023
概括
大动脉动脉瘤在全球造成许多死亡,目前没有药物可以防止其生长或破裂. 本综述探讨了对大动脉动脉瘤机制的当前研究,以改善理解和潜在的治疗方法.
科学领域:
- 心血管医学 心血管医学
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 大动脉动脉瘤是大动脉的危险扩张,往往无症状直到破裂,导致显著的死亡率.
- 目前对大动脉动脉瘤的治疗方法仅限于手术或内血管修复,没有有效的药物治疗方法可用.
- 尽管进行了研究,但关键的致病机制,包括细胞异质性,TGF-β信号传递,炎症和细胞间通信仍然不完全理解.
研究的目的:
- 审查和综合最近关于大动脉动脉瘤病原性机制的研究结果.
- 突出目前关于细胞异质性,信号通路和其他导致大动脉动脉瘤发展的因素的知识差距.
- 提供一个全面的概述,可以提高理解和指导未来治疗动脉动脉瘤的目标识别.
主要方法:
- 对最近关于大动脉动脉瘤病变的研究进行文献综述.
- 综合目前关于细胞机制,信号通路和相关生物过程的发现.
- 分析现有的知识差距和需要进一步研究的领域.
主要成果:
- 大动脉动脉瘤涉及复杂的机制,包括细胞异质性,可塑性和复杂的信号通路,如TGF-β.
- 炎症,细胞死亡,室内新血管和细胞间通信是动脉瘤发展的关键组成部分.
- 尽管取得了进展,但对这些相互关联的机制的完全理解仍然缺乏.
结论:
- 全面了解大动脉动脉瘤的病原体需要进一步调查其复杂的细胞和分子基础.
- 确定新的治疗点需要对细胞异质性,信号通路和炎症过程进行更深入的探索.
- 本综述巩固了当前的知识,为未来的研究提供了基础,旨在开发对大动脉动脉瘤的有效治疗方法.
相关概念视频
Mechanism of Angiogenesis
5.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


